Transcriptome and metabolome changes induced by bitter melon (

AMPK, adenosine monophosphate-activated protein kinase BMJ, bitter melon juice Bitter melon DIO, diet-induced obese Diet intervention HDL, high density lipoprotein (cholesterol) HFD, high fat diet HMDB, Human Metabolome Database High fat diet-induced obesity KEGG, Kyoto Encyclopedia of Genes and Genomes LC-MS, liquid-chromatography mass spectrometry LDL, low density lipoprotein (cholesterol) MetS, Metabolic syndrome Metabolic syndrome Momordica charantia PC, phosphatidylcholine PE, phosphatidylethanolamine PPARs, Peroxisome proliferator-activated receptors

Journal

Journal of traditional and complementary medicine
ISSN: 2225-4110
Titre abrégé: J Tradit Complement Med
Pays: Netherlands
ID NLM: 101605474

Informations de publication

Date de publication:
May 2022
Historique:
received: 22 07 2021
revised: 16 08 2021
accepted: 16 08 2021
entrez: 2 5 2022
pubmed: 3 5 2022
medline: 3 5 2022
Statut: epublish

Résumé

Metabolic syndrome (MetS) is a complex disease of physiological imbalances interrelated to abnormal metabolic conditions, such as abdominal obesity, type II diabetes, dyslipidemia and hypertension. In the present pilot study, we investigated the nutraceutical bitter melon ( Metabolic effects of lyophilized bitter melon juice (BMJ) extract (oral gavage 200 mg/kg/body weight-daily for 40 days) intake were evaluated in diet-induced obese C57BL/6J male mice [fed-high fat diet (HFD), 60 kcal% fat]. Changes in BMJ-mediated changes showed a positive trend towards enhanced glucose homeostasis, vitamin D metabolism and suppression of glycerophospholipid metabolism. In the liver, nuclear peroxisome proliferator-activated receptor (PPAR) and circadian rhythm signaling, as well as bile acid biosynthesis and glycogen metabolism targets were modulated by BMJ (p < 0.05). Thus, our in-depth transcriptomics and metabolomics analysis suggests that BMJ-intake lowers susceptibility to the onset of high-fat diet associated MetS risk factors partly through modulation of PPAR signaling and its downstream targets in circadian rhythm processes to prevent excessive lipogenesis, maintain glucose homeostasis and modify immune responses signaling.

Sections du résumé

Background and aim UNASSIGNED
Metabolic syndrome (MetS) is a complex disease of physiological imbalances interrelated to abnormal metabolic conditions, such as abdominal obesity, type II diabetes, dyslipidemia and hypertension. In the present pilot study, we investigated the nutraceutical bitter melon (
Experimental procedure UNASSIGNED
Metabolic effects of lyophilized bitter melon juice (BMJ) extract (oral gavage 200 mg/kg/body weight-daily for 40 days) intake were evaluated in diet-induced obese C57BL/6J male mice [fed-high fat diet (HFD), 60 kcal% fat]. Changes in
Results and conclusion UNASSIGNED
BMJ-mediated changes showed a positive trend towards enhanced glucose homeostasis, vitamin D metabolism and suppression of glycerophospholipid metabolism. In the liver, nuclear peroxisome proliferator-activated receptor (PPAR) and circadian rhythm signaling, as well as bile acid biosynthesis and glycogen metabolism targets were modulated by BMJ (p < 0.05). Thus, our in-depth transcriptomics and metabolomics analysis suggests that BMJ-intake lowers susceptibility to the onset of high-fat diet associated MetS risk factors partly through modulation of PPAR signaling and its downstream targets in circadian rhythm processes to prevent excessive lipogenesis, maintain glucose homeostasis and modify immune responses signaling.

Identifiants

pubmed: 35493312
doi: 10.1016/j.jtcme.2021.08.011
pii: S2225-4110(21)00103-6
pmc: PMC9039170
doi:

Types de publication

Journal Article

Langues

eng

Pagination

287-301

Informations de copyright

© 2021 Center for Food and Biomolecules, National Taiwan University. Production and hosting by Elsevier Taiwan LLC.

Déclaration de conflit d'intérêts

None.

Références

Biosci Biotechnol Biochem. 2006 Jan;70(1):161-71
pubmed: 16428834
Nutrients. 2017 Mar 29;9(4):
pubmed: 28353634
Anal Chem. 2009 Oct 1;81(19):7974-80
pubmed: 19743813
PLoS Genet. 2016 Aug 17;12(8):e1006011
pubmed: 27532455
Chem Pharm Bull (Tokyo). 2000 Nov;48(11):1673-80
pubmed: 11086895
PLoS Genet. 2018 Jan 10;14(1):e1007171
pubmed: 29320510
Circulation. 2002 Dec 17;106(25):3143-421
pubmed: 12485966
Diabetes. 2015 Jun;64(6):2254-64
pubmed: 25552598
Nucleic Acids Res. 2016 Jan 4;44(D1):D380-4
pubmed: 26590256
Lipids Health Dis. 2017 Sep 29;16(1):186
pubmed: 28962621
Evid Based Complement Alternat Med. 2013;2013:935675
pubmed: 23843889
Int J Oncol. 2015 Apr;46(4):1849-57
pubmed: 25672620
J Nutr Biochem. 2018 Jan;51:1-7
pubmed: 29078075
Nutr J. 2012 Jan 13;11:4
pubmed: 22243626
PPAR Res. 2010;2010:
pubmed: 20871864
J Mol Biol. 2007 Apr 13;367(5):1471-9
pubmed: 17321546
PLoS One. 2012;7(7):e41456
pubmed: 22848500
Bioinformatics. 2014 Jan 1;30(1):133-4
pubmed: 24174567
NCHS Data Brief. 2020 Feb;(360):1-8
pubmed: 32487284
J Intern Med. 2019 Aug;286(2):181-191
pubmed: 31081577
J Biol Chem. 1979 May 10;254(9):3493-6
pubmed: 218970
J Nutr Biochem. 2016 Jul;33:28-35
pubmed: 27260465
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Carcinogenesis. 2019 Sep 18;40(9):1164-1176
pubmed: 31194859
Mol Nutr Food Res. 2015 Apr;59(4):784-94
pubmed: 25631872
PLoS One. 2013 Dec 17;8(12):e84075
pubmed: 24358329
Int J Mol Sci. 2018 Jul 21;19(7):
pubmed: 30037087
J Clin Endocrinol Metab. 2019 Jan 1;104(1):49-56
pubmed: 30137362
Curr Med Chem. 2018;25(22):2545-2565
pubmed: 28322154
Biomed Res Int. 2015;2015:109275
pubmed: 26000280
Nutrients. 2017 Aug 22;9(8):
pubmed: 28829397
J Diabetes. 2010 Sep;2(3):180-93
pubmed: 20923483
Obesity (Silver Spring). 2008 Jan;16(1):205-10
pubmed: 18223637
Circulation. 2004 Nov 16;110(20):3259-69
pubmed: 15533870
Biochim Biophys Acta Biomembr. 2017 Sep;1859(9 Pt B):1558-1572
pubmed: 28411170
J Vis Exp. 2014 Jul 11;(89):
pubmed: 25045913
Drug Discov Ther. 2015 Feb;9(1):70-4
pubmed: 25788054
Br J Nutr. 2005 May;93(5):747-54
pubmed: 15975176
J Biol Chem. 2000 Nov 10;275(45):35368-76
pubmed: 10944538
Am J Clin Nutr. 2016 Aug;104(2):266-79
pubmed: 27305954
Bioinformatics. 2003 Nov 1;19(16):2088-96
pubmed: 14594714
J Clin Invest. 2006 Jul;116(7):1784-92
pubmed: 16823476
Am J Respir Cell Mol Biol. 2013 Aug;49(2):316-23
pubmed: 23590301
J Lipid Res. 2009 Apr;50 Suppl:S138-43
pubmed: 19047759
J Chromatogr A. 2013 Jul 26;1300:217-26
pubmed: 23672979
J Nutr Biochem. 2015 Sep;26(9):938-48
pubmed: 26025327
Am J Physiol Endocrinol Metab. 2006 May;290(5):E916-24
pubmed: 16368784
Molecules. 2016 Jun 22;21(6):
pubmed: 27338339
Dis Model Mech. 2009 May-Jun;2(5-6):231-7
pubmed: 19407331
PLoS One. 2010 Sep 29;5(9):
pubmed: 20927376
Clin Diabetes. 2018 Jul;36(3):217-225
pubmed: 30078941
Nucleic Acids Res. 2016 Jul 8;44(W1):W201-4
pubmed: 27084944
Diabetes Metab Syndr. 2018 May;12(3):393-398
pubmed: 29398635
Life Sci. 2014 Nov 18;118(1):7-14
pubmed: 25445436
J Med Food. 2018 Jul;21(7):672-677
pubmed: 29431598
J Biol Chem. 1998 Oct 16;273(42):27043-6
pubmed: 9765216
Diabetes. 2007 Jun;56(6):1630-7
pubmed: 17363741
J Ethnopharmacol. 2018 Apr 24;216:1-7
pubmed: 29339109
Diabetes Metab Syndr. 2016 Apr-Jun;10(2):105-12
pubmed: 25813139
Toxicol Sci. 2018 Mar 1;162(1):36-42
pubmed: 29106690
J Proteome Res. 2011 Feb 4;10(2):722-31
pubmed: 21047143
Int J Biol Macromol. 2017 Apr;97:544-551
pubmed: 28109806
Cancers (Basel). 2013 Oct 21;5(4):1261-70
pubmed: 24202445
Nutrition. 2017 Apr;36:54-59
pubmed: 28336108
J Ethnopharmacol. 2011 Apr 26;135(1):156-61
pubmed: 21392566
Aging (Albany NY). 2015 Apr;7(4):256-68
pubmed: 25979814
Carcinogenesis. 2013 Jul;34(7):1585-92
pubmed: 23475945
Crit Rev Food Sci Nutr. 2012;52(2):103-12
pubmed: 22059957
J Lipids. 2015;2015:496169
pubmed: 25650336
J Tradit Complement Med. 2021 Feb 12;11(4):356-368
pubmed: 34195030
Int J Obes (Lond). 2008 Jan;32(1):121-8
pubmed: 17653067
J Nutr. 2014 Apr;144(4):475-83
pubmed: 24523491
Diabetes Care. 2011 Jun;34(6):1284-8
pubmed: 21515843
FASEB J. 2019 Apr;33(4):5045-5057
pubmed: 30615497
Prev Chronic Dis. 2017 Mar 16;14:E24
pubmed: 28301314
J Biol Chem. 2010 Jul 16;285(29):22403-13
pubmed: 20452975
Mol Carcinog. 2020 Oct;59(10):1227-1240
pubmed: 32816368
Integr Cancer Ther. 2016 Sep;15(3):376-89
pubmed: 26487740
Mamm Genome. 2015 Feb;26(1-2):43-56
pubmed: 25559016
Am J Cardiol. 2010 Oct 1;106(7):963-8
pubmed: 20854958
Arch Med Sci. 2018 Mar;14(2):422-441
pubmed: 29593818
Diabetes. 2016 Feb;65(2):358-70
pubmed: 26512026
J Atheroscler Thromb. 2005;12(6):295-300
pubmed: 16394610
J Neuroinflammation. 2011 Jun 03;8:64
pubmed: 21639917
J Med Food. 2011 Jan-Feb;14(1-2):86-93
pubmed: 21128828
Chem Biol Interact. 2007 Nov 20;170(2):114-23
pubmed: 17803983
Adv Exp Med Biol. 2010;680:139-47
pubmed: 20865495
J Nutr Biochem. 2015 Mar;26(3):234-40
pubmed: 25488547
J Tradit Complement Med. 2017 Feb 15;7(4):526-531
pubmed: 29034203
Semin Cancer Biol. 2016 Oct;40-41:116-129
pubmed: 27452666
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Cochrane Database Syst Rev. 2010 Feb 17;(2):CD007845
pubmed: 20166099
Lipids Health Dis. 2017 Nov 10;16(1):211
pubmed: 29126447
Circ Res. 2010 Feb 19;106(3):447-62
pubmed: 20167942
Science. 2009 Oct 16;326(5951):437-40
pubmed: 19833968
Stat Appl Genet Mol Biol. 2004;3:Article3
pubmed: 16646809
Circulation. 2005 Oct 25;112(17):2735-52
pubmed: 16157765
J Clin Invest. 2013 Jul;123(7):2764-72
pubmed: 23863634
Cell Metab. 2005 Jan;1(1):15-25
pubmed: 16054041
Sci Adv. 2018 Jul 11;4(7):eaar5319
pubmed: 30116775
Nat Med. 2013 May;19(5):557-66
pubmed: 23652116
Mol Cell Endocrinol. 2013 Feb 25;366(2):163-9
pubmed: 22750052
Open Med Chem J. 2011;5(Suppl 2):70-7
pubmed: 21966327
Phytother Res. 2014 Mar;28(3):363-71
pubmed: 23610006
J Lipid Res. 2001 Mar;42(3):372-8
pubmed: 11254749
J Am Coll Cardiol. 2015 Sep 1;66(9):1050-67
pubmed: 26314534
J Tradit Complement Med. 2020 Apr 08;10(3):245-251
pubmed: 32670819
Nutr Res Pract. 2015 Oct;9(5):489-95
pubmed: 26425278
NCHS Data Brief. 2017 Oct;(288):1-8
pubmed: 29155689
J Nurs Scholarsh. 2013 Mar;45(1):52-9
pubmed: 23368731
Cell Metab. 2014 Feb 4;19(2):193-208
pubmed: 24440037
Obes Rev. 2010 May;11(5):380-8
pubmed: 19694967
Animal Model Exp Med. 2019 Sep 25;2(4):252-258
pubmed: 31942557

Auteurs

Dominique Reed (D)

Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Dileep Kumar (D)

Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Sushil Kumar (S)

Division of Critical Care Medicine and Cardiovascular Pulmonary Research, Departments of Pediatrics and Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Komal Raina (K)

Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Department of Pharmaceutical Sciences, College of Pharmacy and Allied Health Professions, South Dakota State University, Brookings, SD, USA.

Reenu Punia (R)

Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Rama Kant (R)

Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Laura Saba (L)

Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Charmion Cruickshank-Quinn (C)

Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Boris Tabakoff (B)

Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Nichole Reisdorph (N)

Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Michael G Edwards (MG)

Bioinfo Solutions LLC, Parker, CO, USA.

Michael Wempe (M)

Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Chapla Agarwal (C)

Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Rajesh Agarwal (R)

Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Classifications MeSH